About EVERWELL

EVERWELL is a publication dedicated to making cutting-edge science in health, longevity, and biohacking accessible to everyone. Our goal is to break down new research into practical insights while keeping scientific accuracy.

Comments

Post a Comment

Subscribe

Popular posts from this blog

A Pill Instead of Injections: The Orforglipron Study Marks a Turning Point in Obesity Care

Image
  A new study has tested an oral drug called orforglipron, designed to mimic the effects of GLP-1 receptor agonists that are usually given by injection. Unlike injectable versions, this pill can be taken once a day with no restrictions on food or drink, which raises a practical question for anyone considering such treatments: would you be more likely to use something if it came as a pill instead of a shot? The trial, called ATTAIN-1, followed more than 3,000 adults who were overweight or obese for 72 weeks. On average, participants were 45 years old, about two-thirds were women, and their starting weight was just over 103 kilograms. They were randomly assigned to different doses of orforglipron or to placebo, while also following diet and activity guidance. Weight loss results were clear. Those taking the highest dose lost about 11% of their body weight, compared with just 2% on placebo. More than half of the high-dose group lost at least 10% of their body weight, over a third lost...
Read more

Starving Zombie Cells: A New Path in Anti-Aging from Peking University

Image
  Scientists at Peking University may have just uncovered a way to tackle one of aging’s most stubborn problems: the build-up of so-called “zombie cells.” These senescent cells, which stop dividing but refuse to die, accumulate in tissues as we grow older. They leak toxic molecules, disrupt healthy cell function, and drive conditions like brittle bones, clogged arteries, fatty liver disease, and even some cancer relapses. Clearing them has long been a dream of the longevity field. Now, a team in Beijing believes they may have found a practical way to do just that  by cutting off the cells’ food supply. What the researchers discovered is that senescent cells share a peculiar weakness. Unlike normal cells, which can make their own supply of the amino acid asparagine, zombie cells lose this ability. They stop producing the enzyme that synthesizes it and instead become entirely dependent on scavenging asparagine from outside sources. It’s as if healthy cells know how to farm thei...
Read more

Systematic Review Links COVID-19 Vaccines to Short-Term Menstrual Changes, Calls for Deeper Research

Image
  A systematic review of 61 studies has found consistent reports of menstrual changes following COVID-19 vaccination, though the effects appear to be short-term and generally mild. The findings bring data-driven clarity to an issue that first drew widespread attention through anecdotal accounts on social media during the initial months of global vaccination campaigns. Regulatory agencies have already acted on early safety signals. In October 2022, the European Medicines Agency required heavy menstrual bleeding to be listed as a possible side effect of Pfizer and Moderna vaccines. By June of that year, menstrual disorders made up nearly 30% of all vaccine-related reports from women in the European Union. The review, conducted under PRISMA guidelines, analyzed studies across multiple vaccines, including Pfizer, Moderna, AstraZeneca, Johnson & Johnson, Sinopharm, Sputnik V, Sinovac, and others. Pfizer dominated the data, appearing in 79% of studies. The majority of research relied...
Read more